Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users-Reference-Cited by-同舟云学术

Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users

Published:2014-12-01 Issue:12 Volume:174 Page:1974
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Tsui Judith I.¹,Evans Jennifer L.²,Lum Paula J.³,Hahn Judith A.⁴,Page Kimberly⁵

Affiliation:

1. Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts2Department of Medicine, Boston Medical Center, Boston, Massachusetts

2. Department of Epidemiology and Biostatistics, University of California, San Francisco

3. Department of Medicine, University of California, San Francisco

4. Department of Epidemiology and Biostatistics, University of California, San Francisco4Department of Medicine, University of California, San Francisco

5. Division of Epidemiology, Biostatistics and Preventive Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roadblocks for Successful Treatment in Opioid Substitution Therapy Center in India: An Opinion based on Observation;Annals of Indian Psychiatry;2024-09-01

2. Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan;Canadian Family Physician;2024-04

3. Real‐world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada;Journal of Viral Hepatitis;2024-02-22

4. Canadian Addiction Treatment Centre (CATC) opioid agonist treatment cohort in Ontario, Canada;BMJ Open;2024-02

5. US Veterans Health Administration Hepatitis C Virus (HCV) Program: A Model for National HCV Elimination Through Patient-Centered Medical Homes;Clinical Infectious Diseases;2024-01-27